Axiom Brain Health recently launched a new Florida-based mobile research unit that will tour the state to improve accessibility to brain health education and services in Tampa. A ribbon cutting was held Aug. 6 at the New Mt. Zion Baptist Church in Tampa featuring Pastor Larry Roundtree, the experts from Axiom Brain Health, and The […]
Mission Viejo, Aug 12, 2025— Brain health is being taken on the road in Mission Viejo with a Mobile Research Unit that will tour the West Coast to improve accessibility to brain health education and services. The Mobile Research Unit made its debut on August 9 with a ribbon cutting with The Healthy Brain Clinic […]
Florida Mobile Research Unit Launched with Axiom Brain Health at New Mt. Zion Baptist Church Tampa, FL Aug 6, 2025— Brain health is being taken on the road in Tampa as Axiom Brain Health launched a new Florida-based mobile research unit that will tour the state, to improve accessibility to brain health education and […]
Data from Most Deeply Characterized Cohort Across Alzheimer’s Disease Released byGlobal Alzheimer’s Platform Foundation and Alzheimer’s Disease Data Initiative Washington D.C., July 31, 2025 – The Global Alzheimer’s Platform Foundation® (GAP) and the Alzheimer’s Disease Data Initiative (AD Data Initiative) announced today that data generated from the Bio-Hermes-001 study are now publicly available. This release […]
Washington, DC -July 28, 2025 –The Global Alzheimer’s Platform Foundation® (GAP), an international leader in accelerating clinical trials and improving recruitment, announced a collaboration with Genentech, a member of the Roche Group, to expand access to clinical trials for communities underrepresented in Alzheimer’s research. This partnership will leverage the combined expertise of GAP’s Site Alliance […]
Showcase on Bio-Hermes Data Challenge and Poster Presentation to Take Place at the Alzheimer’s Association International Conference (AAIC) Washington D.C., July 23, 2025- The Global Alzheimer’s Platform Foundation® , (GAP) will have a poster presentation and a Featured Research Session at the 2025 Alzheimer’s Association International Conference (AAIC) being held in Toronto, Canada. Poster Presentation […]
IXICO joins collaborative study of new biomarkers designed to improve diagnosis of Alzheimer’s disease and dementias Washington D.C., July 22, 2025 – The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome IXICO, a global leader in neuroscience imaging and biomarker analytics, to the Bio-Hermes-002 study. This collaboration will enhance this unique, observational platform study […]
June 30, 2025 | 1 min read The global alzheimer’s disease diagnostics market size is calculated at USD 8.95 billion in 2024, grows to USD 9.94 billion in 2025, and is projected to reach around USD 25.53 billion by 2034, growing at a CAGR of 11.05% from 2025 to 2034. Rising regulatory approvals, innovative product launches, research funding […]
by: Alex Torres-Perez, Posted: Jun 30, 2025 CENTRAL FALLS, R.I. (WPRI) — Central Falls-based Progreso Latino has been awarded the Global Alzheimer’s Platform Foundation’s prestigious Citizen Scientist Cultivator Award for its work bridging barriers to get more Hispanic people involved in Alzheimer’s studies, which could help millions in the future. Studies show Hispanics are 1.5 times more […]
iLoF, the leading innovator in AI-powered photonics platforms for personalised medicine, announces today a strategic investment from Hamamatsu, the world expert in the development and manufacturing of photonics devices and systems for medical optics and biophotonics, to further its mission of transforming healthcare and driving innovation in medicine. LONDON, Oct. 22, 2024 /PRNewswire/ — iLoF, the leading company […]
Global Researchers Recognized for Trailblazing Projects in First-of-Its-Kind Data Competition Washington D.C., Mar. 27, 2025 – International non-profit organization The Global Alzheimer’s Platform Foundation® (GAP) in collaboration with the Scottish Funding Council’s Brain Health Alliance for Research Challenges (ARC) and the Alzheimer’s Disease Data Initiative proudly announced four winners of the Bio-Hermes Biomarker Data Challenge at the first Data […]
Allison “Allie” Signorelli started sharing her journey with young-onset Parkinson’s on Instagram to create a community with others. Since then, she has joined research studies and teamed up with advocates to spread awareness. News4’s Molette Green reports. View segment here: https://www.nbcwashington.com/community/in-the-community/arlington-woman-shares-young-onset-parkinsons-journey-and-advocates-for-research/3876476
A blood-based diagnostic test for neurodegenerative diseases is a global priority By Zivjena Vucetic 03/21/2025 As the global population ages, the incidence of neurodegenerative diseases such as Alzheimer’s disease (AD) is rapidly increasing. By 2050, the global population of people over the age of 60 is expected to double, reaching 2.1 billion individuals, while those over 80 […]
By Allie Corey Published March 11, 2025 6:01pm EDT FOX 13 News Ironman athlete with Alzheimer’s sets a new goal FOX 13’s Allie Corey highlights Scott Berkheiser, who is inspiring others by competing in the Ironman Triathlon despite being diagnosed with early-onset Alzheimer’s at 55 years old. The Brief TAMPA, Fla. – The Ironman Triathlon is a grueling […]
By Katie Taranto; Published March 10, 2025 at 3:45PM A Dominion Hills woman diagnosed with early-onset Parkinson’s disease received national recognition last month for her advocacy work. Allison Signorelli was honored with the Citizen Scientist Cultivator Award for participating in various research trials after being diagnosed with the disease in 2022 at age 47. Signorelli has spent the […]
International non-profit expands research network to Syracuse to improvecommunity access to research opportunities Washington D.C., Mar. 10, 2025- Global Alzheimer’s Platform Foundation® (GAP) announces the addition of Ichor Research, a leading private a clinical research organization based in Syracuse, New York, to its global network of over 100 best-in-class research sites. Specializing in neurodegenerative clinical trials, […]
GAP Citizen Scientist awards honor individuals’ contributions to research by Andrea Lobo | March 6, 202 A research advocate diagnosed with Parkinson’s disease and a former nurse with Alzheimer’s disease were among recipients of volunteer awards from the Global Alzheimer’s Platform Foundation (GAP).AGAP’s Citizen Scientist Awards acknowledge the contributions of volunteers in clinical trials for neurodegenerative diseases. Each year, GAP’s network of research sites, […]
The free clinical trial at Axiom Brain Health in Tampa works to detect early signs of Alzheimer’s and other cognitive diseases, even years before symptoms appear. Author: Hannah Dineen Published: 4:04 PM EST March 6, 2025 Updated: 8:52 PM EST March 6, 2025 TAMPA, Fla. — It’s estimated nearly 7 million people in the U.S. are living with Alzheimer’s disease. […]
Washington D.C., Feb. 28, 2025 -The Global Alzheimer’s Platform Foundation® (GAP) proudly announced the 2024 National Citizen Scientist Awards® elevated honorees at their 2025 GAP-Net Site Optimization Conference in Miami, Florida. GAP’s Citizen Scientist Awards (CSA) celebrate the contributions of individuals who make a difference by volunteering in clinical trials for neurodegenerative diseases. This year’s […]
Ralph Kern, MD, MHSc, CMO of Cognito Therapeutics, discusses scaling up clinical trials, integrating patient centricity and transitioning from therapeutics to device treatments. February 13, 2025 Tell us about the scientific foundation behind the Spectris ADTM device. Our non-invasive investigational Spectris ADTM device evokes 40 Hz brain gamma oscillations through audiovisual stimulation. It’s delivered in […]
Could a headset with flashing lights and sounds stimulate brain waves and treat Alzheimer’s? Cognito’s Phase 3 trial on such a device is trying to answer that question. Neuropsychologist Dr. Michelle Papka, the trial’s principal investigator and founder of the CRCNJ, explains the science. Researchers and technology companies are investigating whether non-invasive electromagnetic, visual, and […]
The Global Alzheimer’s Platform Foundation® (GAP) is pleased to announce a collaboration with the Biomarkers of Aging Consortium, a consortium dedicated to the developing and validating biomarkers for aging and longevity. Through a memorandum of understanding, the consortium, led by scholars from Harvard University, will gain early access to Bio-Hermes-001 data to investigate the potential for […]
Collaboration to accelerate the investigation of Alzheimer’s disease biomarkers with early access to Bio-Hermes-001 data Washington D.C., Jan. 30, 2025 – The Global Alzheimer’s Platform Foundation® (GAP) is pleased to announce a collaboration with the Biomarkers of Aging Consortium, a consortium dedicated to the developing and validating biomarkers for aging and longevity. Through a memorandum […]
Washington D.C., Jan. 23, 2025 – The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Beckman Coulter Diagnostics as a strategic partner in the Bio-Hermes-002 study. This first-time collaboration will enhance this unique, observational platform study that compares blood-based and digital biomarkers across a broad range of clinical cognitive conditions, MRI and PET images […]